The Arkansas Children’s Research Institute (ACRI) has received $3.2 million from the National Institutes of Health (NIH) to identify how pregnant moms and their babies can better and more safely ...

D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene therapy programs. See more here.

The funding will support the firm's pipeline of mRNA and gene correction therapies, including an investigational inhaled mRNA therapy under testing for cystic fibrosis.

This Friday, October 3rd, the Cystic Fibrosis Foundation will host its Little Rock Finest event at 6:30 p.m. in Argenta Plaza, bringing together the best of the ...

Vertex's revenue was $2.96 billion in the second quarter of 2025, beating the consensus forecast by $58 million. Click here to find out why VRTX is a Buy.

New research from the Arnold School's Department of Epidemiology and Biostatistics has found disparities in mortality rates and life expectancy for Americans living with sickle cell disease or cystic ...

Michael J. Welsh has won the Lasker Award and the 2025 Canada Gairdner International Award for his contributions to cystic fibrosis treatment.